Stock comparison
LeMaitre Vascular
SANUWAVE Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
SNWV
SANUWAVE Health
Market cap
$137.85M
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | SNWV | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 38D | LMAT |
| Benjamin Graham | 81A | 50C | LMAT |
| Philip Fisher | 73B | 54C | LMAT |
| Peter Lynch | 59C | 100A | SNWV |
| Joel Greenblatt | 48D | 57C | SNWV |
| Charlie Munger | 60C | 51C | LMAT |
| Terry Smith | 61C | 44D | LMAT |
Side-by-side metrics
| Metric | LMAT | SNWV |
|---|---|---|
| Market cap | $2.32B | $137.85M |
| P/E (TTM) | 37.1x | 8.6x |
| EV/EBIT | 36.6x | 27.1x |
| ROIC (TTM) | 9.43% | 11.43% |
| Gross margin | 72.39% | 74.75% |
| Net margin | 24.35% | 36.21% |
| Revenue CAGR 5y | 12.75% | 35.65% |
| EPS CAGR 5y | 19.04% | - |
| Debt / Equity | 0.5x | 3.9x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Market cap$2.32Bvs $137.85M+94%
- Debt / Equity0.5xvs 3.9x+88%
SNWV leads on
- P/E (TTM)8.6xvs 37.1x+77%
- Revenue CAGR 5y35.65%vs 12.75%+64%
- Net margin36.21%vs 24.35%+33%
- EV/EBIT27.1xvs 36.6x+26%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.